4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine

C94H122F3N27O3 — CID 162076865

IUPAC4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine
SMILESCc1cnc(Nc2ccc(OC(C)C)nc2)nc1C(C)(C)C.Cc1cnc(Nc2cccc3c2OCCO3)nc1C(C)(C)C.Cc1cnc(Nc2cccc3c2cnn3C)nc1C(C)(C)C.Cc1cnc(Nc2ccnn2C)nc1C(C)(C)C.Cc1cnc(Nc2nn(C)c3ccccc23)nc1C(C)(C)C.Cn1nccc1Nc1ncc(C(F)(F)F)c(C(C)(C)C)n1
InChIInChI=1S/2C17H21N5.C17H24N4O.C17H21N3O2.C13H16F3N5.C13H19N5/c1-11-9-18-16(21-15(11)17(2,3)4)20-13-7-6-8-14-12(13)10-19-22(14)5;1-11-10-18-16(19-14(11)17(2,3)4)20-15-12-8-6-7-9-13(12)22(5)21-15;1-11(2)22-14-8-7-13(10-18-14)20-16-19-9-12(3)15(21-16)17(4,5)6;1-11-10-18-16(20-15(11)17(2,3)4)19-12-6-5-7-13-14(12)22-9-8-21-13;1-12(2,3)10-8(13(14,15)16)7-17-11(20-10)19-9-5-6-18-21(9)4;1-9-8-14-12(17-11(9)13(2,3)4)16-10-6-7-15-18(10)5/h6-10H,1-5H3,(H,18,20,21);6-10H,1-5H3,(H,18,19,20,21);7-11H,1-6H3,(H,19,20,21);5-7,10H,8-9H2,1-4H3,(H,18,19,20);5-7H,1-4H3,(H,17,19,20);6-8H,1-5H3,(H,14,16,17)
InChIKeyZBUYEPSVEPVAGY-UHFFFAOYSA-N
MW1735.19 g/mol
LogP20.86
Rot. Bonds14

About 4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine

4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine (PubChem CID 162076865) has the molecular formula C94H122F3N27O3 and a molecular weight of 1735.19 g/mol. Its IUPAC name is 4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine.

Molecular Properties

Compound Name4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine
PubChem CID162076865
Molecular FormulaC94H122F3N27O3
Molecular Weight1735.19 g/mol
Exact Mass1734.02
IUPAC Name4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine
SMILESCc1cnc(Nc2ccc(OC(C)C)nc2)nc1C(C)(C)C.Cc1cnc(Nc2cccc3c2OCCO3)nc1C(C)(C)C.Cc1cnc(Nc2cccc3c2cnn3C)nc1C(C)(C)C.Cc1cnc(Nc2ccnn2C)nc1C(C)(C)C.Cc1cnc(Nc2nn(C)c3ccccc23)nc1C(C)(C)C.Cn1nccc1Nc1ncc(C(F)(F)F)c(C(C)(C)C)n1
InChIInChI=1S/2C17H21N5.C17H24N4O.C17H21N3O2.C13H16F3N5.C13H19N5/c1-11-9-18-16(21-15(11)17(2,3)4)20-13-7-6-8-14-12(13)10-19-22(14)5;1-11-10-18-16(19-14(11)17(2,3)4)20-15-12-8-6-7-9-13(12)22(5)21-15;1-11(2)22-14-8-7-13(10-18-14)20-16-19-9-12(3)15(21-16)17(4,5)6;1-11-10-18-16(20-15(11)17(2,3)4)19-12-6-5-7-13-14(12)22-9-8-21-13;1-12(2,3)10-8(13(14,15)16)7-17-11(20-10)19-9-5-6-18-21(9)4;1-9-8-14-12(17-11(9)13(2,3)4)16-10-6-7-15-18(10)5/h6-10H,1-5H3,(H,18,20,21);6-10H,1-5H3,(H,18,19,20,21);7-11H,1-6H3,(H,19,20,21);5-7,10H,8-9H2,1-4H3,(H,18,19,20);5-7H,1-4H3,(H,17,19,20);6-8H,1-5H3,(H,14,16,17)
InChIKeyZBUYEPSVEPVAGY-UHFFFAOYSA-N
XLogP20.86
TPSA338.72 Ų
H-Bond Donors6
H-Bond Acceptors30
Rotatable Bonds14
Heavy Atoms127
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001735.19
LogP ≤ 520.86
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1030

Analyze 4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

7-(2,2-difluoroethoxy)-8-[6-(3,5-difluorophenyl)-3-[[[7-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-1,5-naphthyridin-4-yl]amino]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]-N-[[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine
CID 143835060
N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-8-[6-(1-methylpyrazol-4-yl)-3-[[[7-(2,2,2-trifluoroethoxy)-1,5-naphthyridin-4-yl]amino]methyl]-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]-7-(2-pyrazol-1-ylethoxy)-1,5-naphthyridin-4-amine
CID 143835140
3-N-[4-amino-5-morpholin-4-yl-2-(trifluoromethoxy)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-(3-aminophenyl)-1-[6-(3-fluoroanilino)pyrimidin-4-yl]-1,2,4-triazole-3,5-diamine;1-[6-(3-fluoroanilino)pyrimidin-4-yl]-3-N-[3-methoxy-4-(3-morpholin-4-ylpropoxy)phenyl]-1,2,4-triazole-3,5-diamine;1-[6-(3-fluoroanilino)pyrimidin-4-yl]-3-N-(3-methoxyphenyl)-1,2,4-triazole-3,5-diamine;3-N-[2-methoxy-4-[(4-methylpiperazin-1-yl)methyl]phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine
CID 160108760
3-tert-butyl-6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazine;3-tert-butyl-7,8-dihydro-5H-pyrano[4,3-b]pyridine;8-tert-butyl-3,4-dihydro-2H-pyrano[3,2-b]pyridine;6-tert-butyl-3,4-dihydro-2H-pyrano[2,3-c]pyridine;3-tert-butyl-5,6-dihydro-4H-pyrrolo[2,1-e]pyrazole;7-tert-butyl-4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazine;3-tert-butyl-2-methyl-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole;3-tert-butyl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine;2,3-dihydro-[1,4]dioxino[2,3-b]pyridine;3,4-dihydro-1H-isochromene;3,4-dihydro-2H-pyrano[2,3-b]pyridine;6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine;6,6-dimethyl-5,7-dihydropyrazolo[5,1-b][1,3]oxazine;heptakis(2,2-dimethylpropane);ethane;methane;2-methyl-3,4-dihydro-1H-isoquinoline;5,6,7,8-tetrahydroquinoline
CID 160546100
4,4-difluoro-1-methylpiperidin-3-ol;5-(4,4-difluoro-1-methylpiperidin-3-yl)oxy-6-methoxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine;5-fluoro-6-methoxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine;methane
CID 160900570
3-N-[4-amino-5-morpholin-4-yl-2-(trifluoromethoxy)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;1-(6-anilinopyrimidin-4-yl)-3-N-(3-phenylmethoxyphenyl)-1,2,4-triazole-3,5-diamine;1-[6-(3-fluoroanilino)pyrimidin-4-yl]-3-N-[3-methoxy-4-(3-morpholin-4-ylpropoxy)phenyl]-1,2,4-triazole-3,5-diamine;1-[6-(3-fluoroanilino)pyrimidin-4-yl]-3-N-(3-methoxyphenyl)-1,2,4-triazole-3,5-diamine;3-N-(2-fluoro-5-morpholin-4-ylphenyl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine
CID 161453639
7-(2,2-difluoroethoxy)-N-[[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(3,3-difluoropyrrolidin-1-yl)ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(1,4-dioxan-2-ylmethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-[(3R)-3-fluoropyrrolidin-1-yl]ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-1,5-naphthyridin-4-amine;methane
CID 161951266
4-(2,2-difluoropropoxy)-N-[3-methanimidoyl-6-(4-methoxy-3-pyridinyl)-2-methyl-4-pyridinyl]-1,2-dimethylimidazo[4,5-c]pyridin-6-amine;ethane;2-[6-[6-(4-methoxy-3-pyridinyl)-4-methylpyrazolo[4,3-c]pyridin-1-yl]-1,2-dimethylimidazo[4,5-c]pyridin-4-yl]-5-oxa-2-azaspiro[3.4]octane
CID 163273572
5-[(4R)-3,3-difluoro-1-methylpiperidin-4-yl]oxy-6-methoxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;5-[(4S)-3,3-difluoro-1-methylpiperidin-4-yl]oxy-6-methoxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine
CID 163536512
5-[(4R)-3,3-difluoro-1-methylpiperidin-4-yl]oxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-c]pyrimidin-7-yloxy)phenyl]-6-propan-2-yloxyquinazolin-4-amine;5-[(4S)-3,3-difluoro-1-methylpiperidin-4-yl]oxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-c]pyrimidin-7-yloxy)phenyl]-6-propan-2-yloxyquinazolin-4-amine
CID 163737116
5-[(3R)-4,4-difluoro-1-methylpyrrolidin-3-yl]oxy-6-methoxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine;5-[(3S)-4,4-difluoro-1-methylpyrrolidin-3-yl]oxy-6-methoxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine
CID 163764980
5-[(4R)-3,3-difluoro-1-methylpiperidin-4-yl]oxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-c]pyrimidin-7-yloxy)phenyl]-6-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine;5-[(4S)-3,3-difluoro-1-methylpiperidin-4-yl]oxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-c]pyrimidin-7-yloxy)phenyl]-6-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine
CID 163946038

Frequently Asked Questions

What is the IUPAC name of 4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine?
The IUPAC name of 4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine (CID 162076865) is 4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine.
What is the SMILES notation for 4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine?
The canonical SMILES for 4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine is Cc1cnc(Nc2ccc(OC(C)C)nc2)nc1C(C)(C)C.Cc1cnc(Nc2cccc3c2OCCO3)nc1C(C)(C)C.Cc1cnc(Nc2cccc3c2cnn3C)nc1C(C)(C)C.Cc1cnc(Nc2ccnn2C)nc1C(C)(C)C.Cc1cnc(Nc2nn(C)c3ccccc23)nc1C(C)(C)C.Cn1nccc1Nc1ncc(C(F)(F)F)c(C(C)(C)C)n1.
What is the InChIKey of 4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine?
The InChIKey is ZBUYEPSVEPVAGY-UHFFFAOYSA-N. The full InChI is InChI=1S/2C17H21N5.C17H24N4O.C17H21N3O2.C13H16F3N5.C13H19N5/c1-11-9-18-16(21-15(11)17(2,3)4)20-13-7-6-8-14-12(13)10-19-22(14)5;1-11-10-18-16(19-14(11)17(2,3)4)20-15-12-8-6-7-9-13(12)22(5)21-15;1-11(2)22-14-8-7-13(10-18-14)20-16-19-9-12(3)15(21-16)17(4,5)6;1-11-10-18-16(20-15(11)17(2,3)4)19-12-6-5-7-13-14(12)22-9-8-21-13;1-12(2,3)10-8(13(14,15)16)7-17-11(20-10)19-9-5-6-18-21(9)4;1-9-8-14-12(17-11(9)13(2,3)4)16-10-6-7-15-18(10)5/h6-10H,1-5H3,(H,18,20,21);6-10H,1-5H3,(H,18,19,20,21);7-11H,1-6H3,(H,19,20,21);5-7,10H,8-9H2,1-4H3,(H,18,19,20);5-7H,1-4H3,(H,17,19,20);6-8H,1-5H3,(H,14,16,17).
What are the key properties of 4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine?
4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine has a molecular weight of 1735.19 g/mol, XLogP of 20.86, 14 rotatable bonds, 6 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 4-tert-butyl-N-(2,3-dihydro-1,4-benzodioxin-5-yl)-5-methylpyrimidin-2-amine;4-tert-butyl-5-methyl-N-(2-methylpyrazol-3-yl)pyrimidin-2-amine;4-tert-butyl-5-methyl-N-(6-propan-2-yloxy-3-pyridinyl)pyrimidin-2-amine;4-tert-butyl-N-(2-methylpyrazol-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-3-amine;N-(4-tert-butyl-5-methylpyrimidin-2-yl)-1-methylindazol-4-amine is sourced from PubChem (CID 162076865), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).